The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Market Growth Overview

• Current Market Size: The orthobiologics market was valued at $6.65 billion in 2023.
• Short-Term Growth: Expected to rise to $7.08 billion in 2024, with a CAGR of 6.4%.
• Long-Term Growth: Projected to reach $9.12 billion by 2028, growing at a CAGR of 6.5%.

Factors Driving Growth

• Historical Growth Drivers:
  • Increase in orthopedic diseases and conditions.
  • Shift towards minimally invasive procedures.
  • Rise in reconstructive surgeries.
  • Growing healthcare expenditure.
  • Enhanced awareness among patients and providers.
  • Economic development in emerging markets.
• Future Growth Drivers:
  • Aging population and sedentary lifestyles.
  • Continuous advancement in orthobiologic products.
  • Favorable reimbursement policies.
  • New regulatory approvals.
  • Expanded indications for existing products.

View More On The Orthobiologics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Trends Influencing the Market

• Regenerative Medicine: Advances in regenerative medicine are driving innovation.
• Product Innovations: New and improved products are emerging.
• Technological Advancements: Cutting-edge technologies are being developed.
• Strategic Initiatives: Companies are engaging in strategic moves to capture market share.
• Market Expansion: Growing markets in various regions are contributing to overall growth.

Impact of Sports Injuries and Road Accidents

• Growth from Injuries:
  • Increased number of road accidents and sports injuries.
  • High incidence of musculoskeletal damage from these events.
• Treatment Benefits:
  • Orthobiologics aid in faster healing and reducing inflammation.
  • Utilization of bone grafts, growth factors, stem cells, and platelet-rich plasma.
• Statistics:
  • In 2021, US motor vehicle crash fatalities increased by 10.5%, totaling approximately 42,915 deaths.

Innovative Developments

• Dry Allograft Mixtures:
  • New solutions like dry allograft mixtures are enhancing bone healing.
  • Example: Fibrant Liberty allograft by Isto Biologics features robust cortical fibers that support new bone formation and prevent graft migration.

Recent Major Acquisitions

• Zimmer Biomet and Embody:
  • In February 2023, Zimmer Biomet acquired Embody Inc. for $155 million.
  • This acquisition supports Zimmer Biomet’s commitment to innovation in sports medicine with collagen-based biologic products.

Market Segmentation

• By Product Type:
  • Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products.
• By Application:
  • Spinal Fusion, Maxillofacial and Dental, Soft Tissue Repair, Reconstructive and Fracture Surgery, Other Applications.
• By End User:
  • Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users.

Regional Insights

• North America: Dominated the orthobiologics market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

In summary, the orthobiologics market is on a strong upward trajectory, driven by advances in medical technology, increasing prevalence of injuries, and expanding market opportunities. The sector is poised for substantial growth, with innovative developments and strategic acquisitions shaping its future.

Request A Sample Of The Global Orthobiologics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16139&type=smp